253 related articles for article (PubMed ID: 31868000)
1. Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions.
Thiem K; Hoeke G; Zhou E; Hijmans A; Houben T; Boels MG; Mol IM; Lutgens E; Shiri-Sverdlov R; Bussink J; Kanneganti TD; Boon MR; Stienstra R; Tack CJ; Rensen PC; Netea MG; Berbée JF; van Diepen JA
Diab Vasc Dis Res; 2020; 17(1):1479164119892140. PubMed ID: 31868000
[TBL] [Abstract][Full Text] [Related]
2. Deletion of hematopoietic Dectin-2 or CARD9 does not protect against atherosclerotic plaque formation in hyperlipidemic mice.
Thiem K; Hoeke G; van den Berg S; Hijmans A; Jacobs CWM; Zhou E; Mol IM; Mouktaroudi M; Bussink J; Kanneganti TD; Lutgens E; Stienstra R; Tack CJ; Netea MG; Rensen PCN; Berbée JFP; van Diepen JA
Sci Rep; 2019 Mar; 9(1):4337. PubMed ID: 30867470
[TBL] [Abstract][Full Text] [Related]
3. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
[TBL] [Abstract][Full Text] [Related]
4. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic Stabilin-1 deficiency does not influence atherosclerosis susceptibility in LDL receptor knockout mice.
Nahon JE; Hoekstra M; van Hulst S; Manta C; Goerdt S; Geerling JJ; Géraud C; Van Eck M
Atherosclerosis; 2019 Feb; 281():47-55. PubMed ID: 30658191
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.
Kooijman S; Meurs I; van der Stoep M; Habets KL; Lammers B; Berbée JF; Havekes LM; van Eck M; Romijn JA; Korporaal SJ; Rensen PC
J Thromb Haemost; 2015 Jan; 13(1):126-35. PubMed ID: 25345495
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice.
Hirase T; Hara H; Miyazaki Y; Ide N; Nishimoto-Hazuku A; Fujimoto H; Saris CJ; Yoshida H; Node K
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H420-9. PubMed ID: 23729211
[TBL] [Abstract][Full Text] [Related]
8. Map3k8 Modulates Monocyte State and Atherogenesis in ApoE-/- Mice.
Sanz-Garcia C; Sánchez Á; Contreras-Jurado C; Cales C; Barranquero C; Muñoz M; Merino R; Escudero P; Sanz MJ; Osada J; Aranda A; Alemany S
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):237-246. PubMed ID: 27856455
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
[TBL] [Abstract][Full Text] [Related]
11. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.
Brown AL; Zhu X; Rong S; Shewale S; Seo J; Boudyguina E; Gebre AK; Alexander-Miller MA; Parks JS
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2122-30. PubMed ID: 22814747
[TBL] [Abstract][Full Text] [Related]
15. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.
Krishack PA; Bhanvadia CV; Lukens J; Sontag TJ; De Beer MC; Getz GS; Reardon CA
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187995
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue macrophages do not affect atherosclerosis development in mice.
Bijnen M; van de Gaar J; Vroomen M; Gijbels MJ; de Winther M; Schalkwijk CG; Wouters K
Atherosclerosis; 2019 Feb; 281():31-37. PubMed ID: 30654169
[TBL] [Abstract][Full Text] [Related]
17. Progranulin in the hematopoietic compartment protects mice from atherosclerosis.
Nguyen AD; Nguyen TA; Singh RK; Eberlé D; Zhang J; Abate JP; Robles A; Koliwad S; Huang EJ; Maxfield FR; Walther TC; Farese RV
Atherosclerosis; 2018 Oct; 277():145-154. PubMed ID: 30212683
[TBL] [Abstract][Full Text] [Related]
18. Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis.
Galle-Treger L; Moreau M; Ballaire R; Poupel L; Huby T; Sasso E; Troise F; Poti F; Lesnik P; Le Goff W; Gautier EL; Huby T
Cardiovasc Res; 2020 Mar; 116(3):554-565. PubMed ID: 31119270
[TBL] [Abstract][Full Text] [Related]
19. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
